Monday, February 3, 2014

Must READ!! Pew Files Comments to FDA Draft Guidance on 503A

Pew Comments to FDA Draft Guidance on 503A

www.pewhealth.org › Reports & AnalysisIssue Briefs
8 hours ago - Anticipatory compounding is the creation of a drug product prior to receipt of a prescription. Office stock compounding is the creation of a standardized drug ...

No comments: